HK Stock MarketDetailed Quotes

06990 SKB BIO-B

Watchlist
  • 156.000
  • 0.0000.00%
Market Closed Aug 9 16:08 CST
34.76BMarket Cap-54871P/E (TTM)

SKB BIO-B Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
Turnover
91.62%1.54B
--1.05B
2,387.26%803.93M
2,266.02%623.99M
--32.32M
--26.37M
Operating income
91.62%1.54B
1.05B
2,387.26%803.93M
2,266.02%623.99M
32.32M
26.37M
Cost of sales
-182.24%-781.31M
---370.57M
-1,248.74%-276.83M
-991.51%-182.76M
---20.53M
---16.74M
Operating expenses
-182.24%-781.31M
-370.57M
-1,248.74%-276.83M
-991.51%-182.76M
-20.53M
-16.74M
Gross profit
44.03%759.19M
675.66M
4,368.13%527.11M
4,482.29%441.23M
11.8M
9.63M
Selling expenses
---19.53M
----
----
----
----
----
Administrative expenses
-90.84%-181.88M
---89.42M
0.91%-95.3M
17.88%-63.59M
---96.17M
---77.44M
Research and development expenses
-21.87%-1.03B
---490.35M
-16.26%-845.98M
3.58%-513.62M
---727.67M
---532.68M
Special items of operating profit
2,156.07%89.81M
--24.12M
-112.54%-4.37M
-228.96%-28.09M
--34.84M
--21.78M
Operating profit
8.40%-383.38M
120.01M
46.15%-418.55M
71.65%-164.08M
-777.2M
-578.7M
Financing cost
43.35%-84.31M
---78.73M
-32.17%-148.81M
-38.98%-110.43M
---112.59M
---79.46M
Earning before tax
17.57%-467.69M
41.28M
36.24%-567.36M
58.29%-274.51M
-889.8M
-658.16M
Tax
-118.41%-106.44M
---72.41M
---48.74M
---46.72M
----
----
After-tax profit from continuing operations
6.81%-574.13M
-31.13M
30.76%-616.1M
51.19%-321.23M
-889.8M
-658.16M
Earning after tax
6.81%-574.13M
-31.13M
30.76%-616.1M
51.19%-321.23M
-889.8M
-658.16M
Profit attributable to shareholders
6.81%-574.13M
-31.13M
30.76%-616.1M
51.19%-321.23M
-889.8M
-658.16M
Basic earnings per share
50.52%-2.84
-0.17
35.51%-5.74
55.70%-2.99
-8.9
-6.75
Diluted earnings per share
50.52%-2.84
-0.17
35.51%-5.74
55.70%-2.99
-8.9
-6.75
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
KPMG
--
KPMG
--
KPMG
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021
Turnover 91.62%1.54B--1.05B2,387.26%803.93M2,266.02%623.99M--32.32M--26.37M
Operating income 91.62%1.54B1.05B2,387.26%803.93M2,266.02%623.99M32.32M26.37M
Cost of sales -182.24%-781.31M---370.57M-1,248.74%-276.83M-991.51%-182.76M---20.53M---16.74M
Operating expenses -182.24%-781.31M-370.57M-1,248.74%-276.83M-991.51%-182.76M-20.53M-16.74M
Gross profit 44.03%759.19M675.66M4,368.13%527.11M4,482.29%441.23M11.8M9.63M
Selling expenses ---19.53M--------------------
Administrative expenses -90.84%-181.88M---89.42M0.91%-95.3M17.88%-63.59M---96.17M---77.44M
Research and development expenses -21.87%-1.03B---490.35M-16.26%-845.98M3.58%-513.62M---727.67M---532.68M
Special items of operating profit 2,156.07%89.81M--24.12M-112.54%-4.37M-228.96%-28.09M--34.84M--21.78M
Operating profit 8.40%-383.38M120.01M46.15%-418.55M71.65%-164.08M-777.2M-578.7M
Financing cost 43.35%-84.31M---78.73M-32.17%-148.81M-38.98%-110.43M---112.59M---79.46M
Earning before tax 17.57%-467.69M41.28M36.24%-567.36M58.29%-274.51M-889.8M-658.16M
Tax -118.41%-106.44M---72.41M---48.74M---46.72M--------
After-tax profit from continuing operations 6.81%-574.13M-31.13M30.76%-616.1M51.19%-321.23M-889.8M-658.16M
Earning after tax 6.81%-574.13M-31.13M30.76%-616.1M51.19%-321.23M-889.8M-658.16M
Profit attributable to shareholders 6.81%-574.13M-31.13M30.76%-616.1M51.19%-321.23M-889.8M-658.16M
Basic earnings per share 50.52%-2.84-0.1735.51%-5.7455.70%-2.99-8.9-6.75
Diluted earnings per share 50.52%-2.84-0.1735.51%-5.7455.70%-2.99-8.9-6.75
Currency Unit CNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor KPMG--KPMG--KPMG--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg